Showing results (211-220 of 467) with videos related to

Sort By:
Pageof 47
Leukemia|May 8, 2009
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple MyelomaM Dimopoulos, E Terpos, R L Comenzo, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
A double-blind, parallel, comparative evaluation of amlodipine vs. captopril in the monotherapeutic treatment of mild and moderate essential hypertensionM Velasco, A Urbina, H Silva, et al.
Plasmid|July 1, 1988
Cloning, sequencing, and expression in Ficoll-generated minicells of an Escherichia coli heat-stable enterotoxin geneH Stieglitz, L Cervantes, R Robledo, et al.
Neuroscience Letters|November 29, 2013
Hippocampal ether-à-go-go1 potassium channels blockade: effects in the startle reflex and prepulse inhibitionA C Issy, J R Fonseca, L A Pardo, et al.
Methodsx|April 20, 2023
Water quality predictions through linear regression - A brute force algorithm approachA C P Fernandes, A R Fonseca, F A L Pacheco, et al.
European Journal of Case Reports in Internal Medicine|June 12, 2020
Syncope Caused by a Head and Neck Cancer Controlled by a Permanent PacemakerAna Rita Barradas, Francisco Albuquerque, Mariana Constante, et al.
Parasite Immunology|November 29, 2007
Contributions to the study of Trichinella spiralis TSL-1 antigens in host immunityL Yépez-Mulia, R Hernández-Bello, N Arizmendi-Puga, et al.
Leukemia|January 15, 2011
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysisP Kapoor, S V Rajkumar, A Dispenzieri, et al.
Blood Cancer Journal|April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphomaL F Porrata, K M Ristow, T M Habermann, et al.
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
Pageof 47